Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells

Colorectal cancer (CRC) is ranked second for cancer-related deaths worldwide with approximately half of the patients being diagnosed at the late stages. The untimely detection of CRC results in advancement to the metastatic stage and nearly 90% of cancer-related deaths. The early detection of CRC is...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Francis Yew Fu Tieng, Nadiah Abu, Siti Nurmi Nasir, Learn-Han Lee, Nurul-Syakima Ab Mutalib
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/0348e3a2e5c640ea84094bbd43e5931c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0348e3a2e5c640ea84094bbd43e5931c
record_format dspace
spelling oai:doaj.org-article:0348e3a2e5c640ea84094bbd43e5931c2021-11-25T17:21:55ZLiquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells10.3390/diagnostics111121362075-4418https://doaj.org/article/0348e3a2e5c640ea84094bbd43e5931c2021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2136https://doaj.org/toc/2075-4418Colorectal cancer (CRC) is ranked second for cancer-related deaths worldwide with approximately half of the patients being diagnosed at the late stages. The untimely detection of CRC results in advancement to the metastatic stage and nearly 90% of cancer-related deaths. The early detection of CRC is crucial to decrease its overall incidence and mortality rates. The recent introduction of circulating tumor cells (CTCs) has enabled a less invasive sampling method from liquid biopsies, besides revealing key information toward CRC metastasis. The current gold standard for CTC identification is the CellSearch® system (Veridex). This first-generation instrumentation relies on a single cell surface marker (CSM) to capture and count CTCs. Detection of CTCs allows the identification of patients at risk for metastasis, whereas CTC enumeration could improve risk assessment, monitoring of systemic therapy, and detection of therapy resistance in advanced metastatic CRC. In this review, we compared the pros and cons between single CSM-based CTC enrichment techniques and multi-marker-based systems. We also highlighted the challenges faced in the routine implementation of CSM-dependent CTC detection methods in CRC screening, prediction, prognosis, disease monitoring, and therapy selection toward precision medicine, as well as the dwelling on post-CTC analysis and characterization methods.Francis Yew Fu TiengNadiah AbuSiti Nurmi NasirLearn-Han LeeNurul-Syakima Ab MutalibMDPI AGarticlecirculating tumor cells enrichmentcell surface markerscolorectal cancerblood-based screeningnon-invasivemultiplexMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2136, p 2136 (2021)
institution DOAJ
collection DOAJ
language EN
topic circulating tumor cells enrichment
cell surface markers
colorectal cancer
blood-based screening
non-invasive
multiplex
Medicine (General)
R5-920
spellingShingle circulating tumor cells enrichment
cell surface markers
colorectal cancer
blood-based screening
non-invasive
multiplex
Medicine (General)
R5-920
Francis Yew Fu Tieng
Nadiah Abu
Siti Nurmi Nasir
Learn-Han Lee
Nurul-Syakima Ab Mutalib
Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells
description Colorectal cancer (CRC) is ranked second for cancer-related deaths worldwide with approximately half of the patients being diagnosed at the late stages. The untimely detection of CRC results in advancement to the metastatic stage and nearly 90% of cancer-related deaths. The early detection of CRC is crucial to decrease its overall incidence and mortality rates. The recent introduction of circulating tumor cells (CTCs) has enabled a less invasive sampling method from liquid biopsies, besides revealing key information toward CRC metastasis. The current gold standard for CTC identification is the CellSearch® system (Veridex). This first-generation instrumentation relies on a single cell surface marker (CSM) to capture and count CTCs. Detection of CTCs allows the identification of patients at risk for metastasis, whereas CTC enumeration could improve risk assessment, monitoring of systemic therapy, and detection of therapy resistance in advanced metastatic CRC. In this review, we compared the pros and cons between single CSM-based CTC enrichment techniques and multi-marker-based systems. We also highlighted the challenges faced in the routine implementation of CSM-dependent CTC detection methods in CRC screening, prediction, prognosis, disease monitoring, and therapy selection toward precision medicine, as well as the dwelling on post-CTC analysis and characterization methods.
format article
author Francis Yew Fu Tieng
Nadiah Abu
Siti Nurmi Nasir
Learn-Han Lee
Nurul-Syakima Ab Mutalib
author_facet Francis Yew Fu Tieng
Nadiah Abu
Siti Nurmi Nasir
Learn-Han Lee
Nurul-Syakima Ab Mutalib
author_sort Francis Yew Fu Tieng
title Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells
title_short Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells
title_full Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells
title_fullStr Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells
title_full_unstemmed Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells
title_sort liquid biopsy-based colorectal cancer screening via surface markers of circulating tumor cells
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/0348e3a2e5c640ea84094bbd43e5931c
work_keys_str_mv AT francisyewfutieng liquidbiopsybasedcolorectalcancerscreeningviasurfacemarkersofcirculatingtumorcells
AT nadiahabu liquidbiopsybasedcolorectalcancerscreeningviasurfacemarkersofcirculatingtumorcells
AT sitinurminasir liquidbiopsybasedcolorectalcancerscreeningviasurfacemarkersofcirculatingtumorcells
AT learnhanlee liquidbiopsybasedcolorectalcancerscreeningviasurfacemarkersofcirculatingtumorcells
AT nurulsyakimaabmutalib liquidbiopsybasedcolorectalcancerscreeningviasurfacemarkersofcirculatingtumorcells
_version_ 1718412449898561536